Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Mid-Atlantic Epilepsy and

Neither a doctor nor a teaching hospital

Research payments

$99,201

21 payments

Through program year 2025, Mid-Atlantic Epilepsy and is reported as receiving $99,201 in research payments, across 21 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $40,148 13
2024 Research $28,590 4
2023 Research $30,462 4

Breakdown

Who paid Research payments · program years 2023–2025
  1. SK Life Science, Inc. $92,823 18 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $6,378 3 payments
Studies the money was for Research payments · program years 2023–2025
  1. Ykp509c003 $82,931 17 payments
  2. Ykp3089c025 $9,892 1 payment
  3. A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome $6,378 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record